Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies - Restructuring Charges (Details)

Basis of Presentation and Summary of Significant Accounting Policies - Restructuring Charges (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2022	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2023
Restructuring costs, net of adjustments	$ 1,550			$ 12,974
Accrued restructuring actions balances	3,761
Restructuring costs	1,273	$ 11,424
Cash payments	(3,239)	(1,434)
Non-cash adjustments	(843)	(6,229)
Adjustments	277
Accrued restructuring actions balances	1,229	3,761		1,229
Corporate
Restructuring costs, net of adjustments	253			1,478
Diagnostics and Genomics
Restructuring costs, net of adjustments	355			1,094
Protein Sciences
Restructuring costs, net of adjustments	942			10,402
Protein Sciences \| QT Holdings Corporation
Restructuring costs			$ 2,170
Cash payments					$ (2,005)
Adjustments					(165)
Cost of Sales
Restructuring costs, net of adjustments	647			1,821
Selling, General and Administrative Expenses
Restructuring costs, net of adjustments	903			11,153
Selling, General and Administrative Expenses \| Protein Sciences \| QT Holdings Corporation
Restructuring costs						$ 2,170
Employee severance
Restructuring costs, net of adjustments	410			5,292
Accrued restructuring actions balances	3,625
Restructuring costs	133	4,882
Cash payments	(2,806)	(1,257)
Adjustments	277
Accrued restructuring actions balances	1,229	3,625		1,229
Employee severance \| Corporate
Restructuring costs, net of adjustments	117			1,310
Employee severance \| Diagnostics and Genomics
Restructuring costs, net of adjustments	265			1,004
Employee severance \| Protein Sciences
Restructuring costs, net of adjustments	28			2,978
Accrued restructuring actions balances				897
Restructuring costs						1,677
Cash payments				(1,006)		(762)
Adjustments				221		18
Accrued restructuring actions balances	112			112	897	897
Employee severance \| Protein Sciences \| QT Holdings Corporation
Restructuring costs			1,328
Cash payments					(1,233)
Adjustments					(95)
Employee severance \| Selling, General and Administrative Expenses \| Protein Sciences \| QT Holdings Corporation
Restructuring costs						1,328
Asset-related and other
Restructuring costs, net of adjustments	1,140			1,644
Accrued restructuring actions balances	136
Restructuring costs	1,140	504
Cash payments	(433)	(177)
Non-cash adjustments	(843)	(191)
Accrued restructuring actions balances		136
Asset-related and other \| Corporate
Restructuring costs, net of adjustments	136			168
Asset-related and other \| Diagnostics and Genomics
Restructuring costs, net of adjustments	90			90
Asset-related and other \| Protein Sciences
Restructuring costs, net of adjustments	$ 914			1,386
Impairment of assets held-for-sale
Restructuring costs, net of adjustments				6,038
Restructuring costs		6,038
Non-cash adjustments		$ (6,038)
Impairment of assets held-for-sale \| Protein Sciences
Restructuring costs, net of adjustments				$ 6,038
Asset impairment and other \| Protein Sciences \| QT Holdings Corporation
Restructuring costs			$ 842
Cash payments					(772)
Adjustments					$ (70)
Asset impairment and other \| Selling, General and Administrative Expenses \| Protein Sciences \| QT Holdings Corporation
Restructuring costs						$ 842